Budapest, Hungary

Laszlo Madi-Szabo

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar of Debrecen and Alkaloida Vegyeszeti Gyar of. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laszlo Madi-Szabo: Innovator in Pharmaceutical Compositions

Introduction

Laszlo Madi-Szabo is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that have anti-pancreatic inflammatory effects. His work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Laszlo holds a patent for pharmaceutical compositions that target pancreatic inflammation. This innovation is crucial for addressing various health issues related to pancreatic conditions. He has 1 patent to his name, showcasing his commitment to research and development in this vital area.

Career Highlights

Laszlo is associated with Biogal Gyogyszergyar in Debrecen and Alkaloida Vegyeszeti Gyar. His role in these companies allows him to collaborate with other experts in the field and contribute to the development of effective pharmaceutical solutions. His dedication to innovation is evident in his work and the impact it has on healthcare.

Collaborations

Laszlo has worked alongside talented colleagues, including Margit Morvai and Eva Horvath Nee Feher. These collaborations enhance the research environment and foster the exchange of ideas, leading to more effective solutions in the pharmaceutical industry.

Conclusion

Laszlo Madi-Szabo is a distinguished inventor whose work in pharmaceutical compositions is making a difference in the medical field. His contributions are vital for advancing treatments for pancreatic inflammation, and his collaborations with other professionals further enhance the impact of his innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…